MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2025 International Congress

    Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.

    MB. Charra Castellani, MV. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Evaluate the quality of life and the presence of anxiety and depression in HFS patients and their behavior after botulinum toxin administration. Background: Hemifacial…
  • 2025 International Congress

    Hypersensitivity Reaction to Abobotulinumtoxin: A Case Report

    T. Le, M. Christie (Houston, USA)

    Objective: To report a case of hypersensitivity reaction to abobotulinumtoxinA injections for spasticity in a patient who did not have hypersensitivity to onabotulinumtoxinA and raise…
  • 2025 International Congress

    Simple and Effective OnabotulinumtoxinA Injection Technique for Hemifacial Spasm

    K. Fungpunyaroj, P. Chairangsaris (Bangkok, Thailand)

    Objective: In order to determine fixed-site and fixed-dose BoNT injections for HFS were easy to administer, safe, efficacious, well-tolerated, and practical this study aims to…
  • 2025 International Congress

    Physician Assessment of Non-Medical Toxin Switching on Patient Care

    P. Charles, L. Venditti, M. Nelson, R. Singh, K. Pazira, H. Kling, L. Kopaeva, S. Sharp, K. Harper (Nashville, USA)

    Objective: To gain an understanding from physicians on the impact of non-medical toxin switching (NMTS) in the treatment of movement disorders and other chronic conditions…
  • 2025 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 6-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea. Background: Sialorrhea is frequently a…
  • 2025 International Congress

    Botulinium toxin in treatment of Parkinsonism

    A. Wankar (Nagpur, India)

    Objective: This review discusses the use of BT in various motor and non-motor symptoms of Parkinsonism. This review discusses the use of BT in various…
  • 2025 International Congress

    Management of Grisel’s Syndrome with Botulinum Toxin: A Case Report

    L. Kenjaeva, A. Azimov, G. Kendjaeva (Tashkent, Uzbekistan)

    Objective: To present a case of Grisel’s syndrome (GS), highlighting challenges and the efficacy of botulinum toxin therapy in treatment. Background: Grisel’s syndrome (GS) is…
  • 2025 International Congress

    Effectiveness, Safety, and Quality of Life Outcomes of Neurotoxin Injections in the Treatment of Essential Tremors: A Systematic Review

    YJ. Rabe, A. Yu, JR. Yu, D. Simpson (San Juan City, Philippines)

    Objective: This systematic review aims to evaluate the outcomes of neurotoxins such as botulinum neurotoxin (BoNT) injections as a therapeutic intervention for essential tremors with…
  • 2025 International Congress

    Lower Eyelids Botulinum Injections: Improving Dry Eye and Prolonging Therapeutic Effect

    M. Cohen, L. Berkovitz, H. Totah, Y. Shechter, G. Yahalom (jerusalem, Israel)

    Objective: This study explores botulinum toxin (BT) injection techniques to optimize outcomes for patients with facial disorders, focusing on improving dry eye. Background: Dry eye…
  • 2025 International Congress

    Hemiballism after MRI guided focused ultrasound thalamotomy for essential tremor

    M. Govil, N. Beltre, P. Drummond (New York, USA)

    Objective: To report a case of hemiballism as a previously unreported complication of MRI-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor (ET). Background: MRgFUS of…
  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley